Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

The Calmer Co International Ltd

Company price
0.001 AUD 0.00(0%)
Last update at 2026-11-11T22:59:00Z
VOLUME
2000000
Market Cap
5.34M

Momentum Score

…

The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, New Zealand, the United States, and internationally. It operates through four segments: Fiji Kava Trading, SPE Fiji, Fiji Kava USA, and Danodan. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; flavoured and non-flavoured kava shots, tinctures, and traditional and instant drinking kava under the Taki Mai brand name; hemp, CBD oils, topical salves, and pet CBD oils under Danodan brand name. In addition, it sells its products through retailers and online. The company was formerly known as Fiji Kava Limited and changed its name to The Calmer Co International Limited in April 2023. The Calmer Co International Limited was incorporated in 2014 and is based in Yeronga, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on The Calmer Co International Ltd (ASX: CCO) is limited; available disclosures indicate it is a consumer wellness company selling branded wellbeing products. Long-term growth drivers that could support the business include rising consumer focus on mental health, expansion of e-commerce and international distribution, and product innovation, which may make it attractive if it can scale brand and distribution.
Key investment risks include limited financial disclosure and small scale that heighten execution and financing risk, intense competition in consumer wellness, and regulatory developments that could materially affect revenue.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
8.12M
Revenue Per Share
0.00
Gross Profit TTM
2.78M
Debt / Equity
-8.59
ROE
-524.61%
Net Debt
3.21M
ROCE
-434.94%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -3.81M -3.99M -3.73M -5.24M -5.46M
Net income -3.81M -3.99M -3.73M -5.24M -5.46M
Selling general administrative - 0.64M 2.17M 1.97M 2.09M
Selling and marketing expenses - 2.53M 1.22M 0.87M 2.07M
Gross profit 0.83M 3.48M 2.05M -1.40M 0.67M
Reconciled depreciation - - 0.20M - -
Ebit -3.39M -3.57M -3.54M -4.30M -5.42M
Ebitda -3.00M -3.45M -3.34M -4.07M -5.28M
Depreciation and amortization 0.39M 0.12M 0.20M 0.23M 0.15M
Operating income -3.39M -2.20M -1.88M -4.30M -5.42M
Other operating expenses 11.51M 10.23M 6.15M 6.08M 7.50M
Interest expense 0.37M 0.20M 0.17M 0.26M 0.04M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - 0.23M 0.00M 0.26M 0.05M
Net interest income - - -0.17M - -
Income tax expense - - -0.00M -0.00M 0.03M
Total revenue 8.12M 8.03M 4.26M 1.78M 2.08M
Total operating expenses 4.22M 5.68M 3.93M 2.89M 6.08M
Cost of revenue 7.29M 4.55M 2.21M 3.19M 1.42M
Total other income expense net -0.42M -1.80M -1.84M -0.94M -0.01M
Net income from continuing ops - - -3.73M - -
Net income applicable to common shares - -3.99M -3.73M -5.24M -5.92M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 4.91M 5.68M 4.33M 3.24M 4.79M
Intangible assets 0.36M 0.42M - 0.47M 0.88M
Other current assets 0.21M 0.64M 0.09M - 0.52M
Total liab 5.36M 3.78M 4.80M 3.32M 2.51M
Total stockholder equity -0.45M 1.90M -0.47M -0.09M 2.28M
Other current liab 0.63M 0.73M 0.76M - 0.97M
Common stock 36.46M 34.97M 28.77M 25.39M 22.30M
Retained earnings -37.19M -33.38M -29.39M -25.48M -19.86M
Good will - - - - 0.33M
Cash 0.67M 1.46M 1.07M - 0.80M
Cash and equivalents - - - 0.46M 0.81M
Total current liabilities 4.13M 2.10M 3.25M 2.43M 0.97M
Current deferred revenue 0.01M - 0.69M - 0.02M
Net debt 3.21M 0.85M 1.15M - 0.28M
Short term debt 2.68M 0.64M 0.67M 0.22M 0.14M
Short long term debt total 3.88M 2.31M 2.21M - 1.08M
Other stockholder equity - - - - -0.67M
Property plant equipment - - - 0.96M 0.91M
Total current assets 2.98M 4.12M 3.08M 1.81M 2.99M
Short term investments - 0.03M 0.03M - -
Net receivables 0.76M 0.47M 0.64M 0.30M 0.21M
Long term debt - - - 0.89M 1.53M
Inventory 1.34M 1.56M 1.25M 0.88M 1.49M
Accounts payable 0.81M 0.73M 1.12M - 0.33M
Accumulated other comprehensive income 0.28M 0.32M 0.16M - 0.51M
Non currrent assets other - - 0.47M - -0.00M
Non current assets total 1.93M 1.56M 1.26M - 1.79M
Long term debt total - - - 0.89M 1.53M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - -0.12M - -
Total cashflows from investing activities -0.05M -0.46M -0.12M -0.02M -0.97M
Total cash from financing activities 2.19M 5.19M 2.83M 3.47M 6.03M
Net income -3.81M -3.99M -3.73M -5.24M -5.92M
Change in cash -0.76M 0.36M 0.64M -0.35M -0.38M
Begin period cash flow 1.43M 1.10M 0.46M 0.78M 1.18M
End period cash flow 0.67M 1.46M 1.10M 0.43M 0.80M
Total cash from operating activities -2.94M -4.37M -2.08M -3.80M -6.14M
Issuance of capital stock - - 2.27M - -
Depreciation 0.39M 0.28M 0.20M 0.23M 0.15M
Other cashflows from investing activities - - -0.05M - -
Change to inventory 0.21M -0.30M -0.37M 0.60M -1.46M
Change to account receivables -0.16M -0.38M -0.26M 0.24M 0.74M
Sale purchase of stock - 5.27M 2.27M 3.09M 5.24M
Other cashflows from financing activities -0.20M - -0.04M 0.83M 2.31M
Capital expenditures 0.05M 0.46M 0.12M 0.02M 0.96M
Change in working capital 0.45M -0.67M 1.17M 1.19M -0.42M
Stock based compensation - 0.28M 0.12M 0.07M -
Other non cash items 0.03M -0.27M 0.17M -0.40M 0.05M
Free cash flow -2.98M -4.83M -2.19M -3.82M -7.10M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CCO
The Calmer Co International Ltd
-
-%
0.00 - - 0.66 28.50 1.05 -0.54
A2M
The a2 Milk Company Ltd
-0.07
0.96%
7.19 29.04 28.74 2.68 5.94 2.85 17.82
BGA
Bega Cheese Ltd
-0.02
0.30%
6.74 35.61 22.94 0.52 1.93 0.60 11.82
CBO
Cobram Estate Olives Ltd
-0.06
2.26%
2.59 - - 4.79 2.48 6.63 185.44
RIC
Ridley Corporation Ltd
0.02
0.74%
2.74 38.29 13.42 0.35 2.01 0.53 4.50

Profile*

The Calmer Co International Ltd

The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, New Zealand, the United States, and internationally. It operates through four segments: Fiji Kava Trading, SPE Fiji, Fiji Kava USA, and Danodan. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; flavoured and non-flavoured kava shots, tinctures, and traditional and instant drinking kava under the Taki Mai brand name; hemp, CBD oils, topical salves, and pet CBD oils under Danodan brand name. In addition, it sells its products through retailers and online. The company was formerly known as Fiji Kava Limited and changed its name to The Calmer Co International Limited in April 2023. The Calmer Co International Limited was incorporated in 2014 and is based in Yeronga, Australia.

24 Cansdale Street, Yeronga, QLD, Australia, 4104

61 4 2921 0031

Name Title Year Born
Dr. Anthony Noble MD, CEO & Director NA
Mr. Zane Yoshida B.Tech., M.B.A. Founder, COO & Executive Director NA
Dr. Anthony Noble MD, CEO & Director NA
Mr. Zane Yoshida B.Tech., M.B.A. Founder, COO & Executive Director NA
Ms. Sharmila Nanayakkara Chief Financial Officer NA
Prof. Jerome Sarris Member Scientific Advisory Board & Chief Scientist NA
Mr. Brian Casutto Managing Director of FijiKava Inc (USA) 1971
Ms. Natalie Climo Company Secretary NA
Dr. Anthony Noble MD, CEO & Director NA
Mr. Zane Yoshida B.Tech., M.B.A. Founder, COO & Executive Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…